WASHINGTON/NEW YORK (Reuters) - Health regulators approved Vertex Pharmaceuticals' Kalydeco, the first drug designed to treat the underlying cause of cystic fibrosis, a rare genetic disease.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/jPUIi0Jhh_8/us-fda-vertex-kalydeco-idUSTRE80U1JA20120131
save money travel make money best news online money internet business
No comments:
Post a Comment